IL23R and arthritic joint disease: Targeting IL-23R in the HLA-B27 transgenic rat, an experimental model that closely resembles human SpA, was not effective once arthritis was established but did have some beneficial impact in preventing the onset of disease, indicating IL-23 independent production of IL-17 in the perpetuation of disease (38).